1. Home
  2. LOB vs NVCR Comparison

LOB vs NVCR Comparison

Compare LOB & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

HOLD

Current Price

$40.76

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.16

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOB
NVCR
Founded
2008
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
LOB
NVCR
Price
$40.76
$15.16
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$43.00
$28.08
AVG Volume (30 Days)
253.8K
1.5M
Earning Date
04-22-2026
04-30-2026
Dividend Yield
0.32%
N/A
EPS Growth
31.95
21.79
EPS
0.60
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$35.52
$7.72
Revenue Next Year
$16.03
$6.74
P/E Ratio
$68.27
N/A
Revenue Growth
N/A
8.28
52 Week Low
$29.36
$9.82
52 Week High
$42.89
$18.92

Technical Indicators

Market Signals
Indicator
LOB
NVCR
Relative Strength Index (RSI) 65.86 44.32
Support Level $39.43 $14.85
Resistance Level $42.72 $15.19
Average True Range (ATR) 0.99 0.87
MACD 0.25 -0.33
Stochastic Oscillator 85.08 34.48

Price Performance

Historical Comparison
LOB
NVCR

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: